Deciphering the Molecular Traits of Non-canonical Responders to Advance Personalized Therapy in Gastric Cancer
NCT06877910 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2025-03-14
Summary
Retrospective-prospective observational study in which a novel whole-exome sequencing (WES) approach will be used in association with whole-transcriptome sequencing (WTS) to analyze two independent and equally sized cohorts of patients with mGC.
Conditions
- Metastatic Gastric Cancer
Sponsors & Collaborators
-
Regina Elena Cancer Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-10
- Primary Completion
- 2023-06-20
- Completion
- 2026-01-10
Countries
- Italy
Study Locations
More Related Trials
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Molecular Screening for Cancer Treatment Optimization
NCT01566019 ·Status: UNKNOWN ·Phase: NA
-
Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions
NCT01457196 ·Status: COMPLETED ·Phase: NA
-
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948 ·Status: UNKNOWN
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing.
NCT06929910 ·Status: RECRUITING
-
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
NCT06202131 ·Status: RECRUITING
-
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
NCT07277920 ·Status: RECRUITING
-
Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA
NCT05668910 ·Status: UNKNOWN
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
NCT04665687 ·Status: RECRUITING
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer
NCT02790944 ·Status: COMPLETED
-
Mutational Oncology in Clinical Practice
NCT06020625 ·Status: RECRUITING ·Phase: NA
-
GENomic PROfilation for Therapeutic Purposes in SARComas and Molecular Tumor Board (MTB): Retrospective/Prospective Study in Referral Centers
NCT06076070 ·Status: UNKNOWN
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Analysis of Molecular Biomarkers in Periocular Adnexal Tumours
NCT06080009 ·Status: RECRUITING ·Phase: NA
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
NCT07224750 ·Status: RECRUITING
-
Characterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatients
NCT02626039 ·Status: COMPLETED
-
Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
NCT00954655 ·Status: COMPLETED
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
What Benefit of a Full Analysis of Exome? Routine Care Study in Patients With Solid Tumors
NCT02840604 ·Status: COMPLETED